Genipin-Cross-Linked Chitosan Nerve Conduits Containing TNF-α Inhibitors for Peripheral Nerve Repair

Article
  • 32 Downloads

Abstract

Tissue engineered nerve grafts (TENGs) are considered a promising alternative to autologous nerve grafting, which is considered the “gold standard” clinical strategy for peripheral nerve repair. Here, we immobilized tumor necrosis factor-α (TNF-α) inhibitors onto a nerve conduit, which was introduced into a chitosan (CS) matrix scaffold utilizing genipin (GP) as the crosslinking agent, to fabricate CS-GP-TNF-α inhibitor nerve conduits. The in vitro release kinetics of TNF-α inhibitors from the CS-GP-TNF-α inhibitor nerve conduits were investigated using high-performance liquid chromatography. The in vivo continuous release profile of the TNF-α inhibitors released from the CS-GP-TNF-α inhibitor nerve conduits was measured using an enzyme-linked immunosorbent assay over 14 days. We found that the amount of TNF-α inhibitors released decreased with time after the bridging of the sciatic nerve defects in rats. Moreover, 4 and 12 weeks after surgery, histological analyses and functional evaluations were carried out to assess the influence of the TENG on regeneration. Immunochemistry performed 4 weeks after grafting to assess early regeneration outcomes revealed that the TENG strikingly promoted axonal outgrowth. Twelve weeks after grafting, the TENG accelerated myelin sheath formation, as well as functional restoration. In general, the regenerative outcomes following TENG more closely paralleled findings observed with autologous grafting than the use of the CS matrix scaffold. Collectively, our data indicate that the CS-GP-TNF-α inhibitor nerve conduits comprised an elaborate system for sustained release of TNF-α inhibitors in vitro, while studies in vivo demonstrated that the TENG could accelerate regenerating axonal outgrowth and functional restoration. The introduction of CS-GP-TNF-α-inhibitor nerve conduits into a scaffold may contribute to an efficient and adaptive immune microenvironment that can be used to facilitate peripheral nerve repair.

Keywords

Tissue engineered nerve grafts (TENGs) Tumor necrosis factor-α (TNF-α) Peripheral nerve regeneration Genipin Schwann cells 

Notes

Acknowledgments

We appreciate the financial support from the National Key Research and Development Program of China (No. 2016YFC1101603), National Natural Science Foundation of China (Nos. 81370043 and 81671823), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).

Author Contributions

XT and YY designed the research; LZ, WZ, CN, YZ, HS and XT performed the experiments; LZ, CN, YZ, HS, YW, YY, and XT analyzed data; XT wrote the paper.

Conflict of interest

The authors declare no conflicts of interest.

References

  1. 1.
    Akerman, P., P. Cote, S. Q. Yang, C. McClain, S. Nelson, G. J. Bagby, et al. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am. J. Physiol. 263:G579–G585, 1992.PubMedGoogle Scholar
  2. 2.
    Avellino, A. M., D. Hart, A. T. Dailey, M. MacKinnon, D. Ellegala, and M. Kliot. Differential macrophage responses in the peripheral and central nervous system during wallerian degeneration of axons. Exp. Neurol. 136:183–198, 1995.CrossRefPubMedGoogle Scholar
  3. 3.
    Battiston, B., P. Titolo, D. Ciclamini, and B. Panero. Peripheral nerve defects: overviews of practice in Europe. Hand Clin. 33:545–550, 2017.CrossRefPubMedGoogle Scholar
  4. 4.
    Chiono, V., and C. Tonda-Turo. Trends in the design of nerve guidance channels in peripheral nerve tissue engineering. Prog. Neurobiol. 131:87–104, 2015.CrossRefPubMedGoogle Scholar
  5. 5.
    Cressman, D. E., L. E. Greenbaum, R. A. DeAngelis, G. Ciliberto, E. E. Furth, V. Poli, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science. 274:1379–1383, 1996.CrossRefPubMedGoogle Scholar
  6. 6.
    Dalamagkas, K., M. Tsintou, and A. Seifalian. Advances in peripheral nervous system regenerative therapeutic strategies: a biomaterials approach. Mater. Sci. Eng. C. 65:425–432, 2016.CrossRefGoogle Scholar
  7. 7.
    Freeman, M. R. Signaling mechanisms regulating Wallerian degeneration. Curr. Opin. Neurobiol. 27:224–231, 2014.CrossRefPubMedGoogle Scholar
  8. 8.
    Gnavi, S., C. Barwig, T. Freier, K. Haastert-Talini, C. Grothe, and S. Geuna. The use of chitosan-based scaffolds to enhance regeneration in the nervous system. Int. Rev. Neurobiol. 109:1–62, 2013.CrossRefPubMedGoogle Scholar
  9. 9.
    Gomez-Sanchez, J. A., L. Carty, M. Iruarrizaga-Lejarreta, M. Palomo-Irigoyen, M. Varela-Rey, M. Griffith, et al. Schwann cell autophagy, myelinophagy, initiates myelin clearance from injured nerves. J. Cell Biol. 210:153–168, 2015.CrossRefPubMedCentralPubMedGoogle Scholar
  10. 10.
    Gu, X., F. Ding, and D. F. Williams. Neural tissue engineering options for peripheral nerve regeneration. Biomaterials. 35:6143–6156, 2014.CrossRefPubMedGoogle Scholar
  11. 11.
    Gu, X., F. Ding, Y. Yang, and J. Liu. Construction of tissue engineered nerve grafts and their application in peripheral nerve regeneration. Prog. Neurobiol. 93:204–230, 2011.CrossRefPubMedGoogle Scholar
  12. 12.
    Gurtner, G. C., S. Werner, Y. Barrandon, and M. T. Longaker. Wound repair and regeneration. Nature. 453:314–321, 2008.CrossRefPubMedGoogle Scholar
  13. 13.
    He, Z., and Y. Jin. Intrinsic control of axon regeneration. Neuron. 90:437–451, 2016.CrossRefPubMedGoogle Scholar
  14. 14.
    Huebner, E. A., and S. M. Strittmatter. Axon regeneration in the peripheral and central nervous systems. Results Probl. Cell Differ. 48:339–351, 2009.PubMedCentralPubMedGoogle Scholar
  15. 15.
    Jang, S. Y., B. A. Yoon, Y. K. Shin, S. H. Yun, Y. R. Jo, Y. Y. Choi, et al. Schwann cell dedifferentiation-associated demyelination leads to exocytotic myelin clearance in inflammatory segmental demyelination. Glia. 65:1848–1862, 2017.CrossRefPubMedGoogle Scholar
  16. 16.
    Karin, M., and H. Clevers. Reparative inflammation takes charge of tissue regeneration. Nature. 529:307–315, 2016.CrossRefPubMedCentralPubMedGoogle Scholar
  17. 17.
    Koppes, R. A., S. Park, T. Hood, X. Jia, N. Abdolrahim Poorheravi, A. H. Achyuta, et al. Thermally drawn fibers as nerve guidance scaffolds. Biomaterials. 81:27–35, 2016.CrossRefPubMedGoogle Scholar
  18. 18.
    Leung, L., and C. M. Cahill. TNF-alpha and neuropathic pain–a review. J. Neuroinflamm. 7:27, 2010.CrossRefGoogle Scholar
  19. 19.
    Li, S., C. Xue, Y. Yuan, R. Zhang, Y. Wang, Y. Wang, et al. The transcriptional landscape of dorsal root ganglia after sciatic nerve transection. Sci. Rep. 5:16888, 2015.CrossRefPubMedCentralPubMedGoogle Scholar
  20. 20.
    Liu, Y., L. J. Zhou, J. Wang, D. Li, W. J. Ren, J. Peng, et al. TNF-alpha differentially regulates synaptic plasticity in the hippocampus and spinal cord by microglia-dependent mechanisms after peripheral nerve injury. J. Neurosci. 37:871–881, 2017.CrossRefPubMedCentralPubMedGoogle Scholar
  21. 21.
    Martini, R., S. Fischer, R. Lopez-Vales, and S. David. Interactions between Schwann cells and macrophages in injury and inherited demyelinating disease. Glia. 56:1566–1577, 2008.CrossRefPubMedGoogle Scholar
  22. 22.
    Mc Guire, C., R. Beyaert, and G. van Loo. Death receptor signalling in central nervous system inflammation and demyelination. Trends Neurosci. 34:619–628, 2011.CrossRefPubMedGoogle Scholar
  23. 23.
    Pabari, A., S. Y. Yang, A. M. Seifalian, and A. Mosahebi. Modern surgical management of peripheral nerve gap. JPRAS. 63:1941–1948, 2010.PubMedGoogle Scholar
  24. 24.
    Pateman, C. J., A. J. Harding, A. Glen, C. S. Taylor, C. R. Christmas, P. P. Robinson, et al. Nerve guides manufactured from photocurable polymers to aid peripheral nerve repair. Biomaterials. 49:77–89, 2015.CrossRefPubMedGoogle Scholar
  25. 25.
    Raimondo, S., M. Fornaro, P. Tos, B. Battiston, M. G. Giacobini-Robecchi, and S. Geuna. Perspectives in regeneration and tissue engineering of peripheral nerves. Ann. Anat. 193:334–340, 2011.CrossRefPubMedGoogle Scholar
  26. 26.
    Sadtler, K., K. Estrellas, B. W. Allen, M. T. Wolf, H. Fan, A. J. Tam, et al. Developing a pro-regenerative biomaterial scaffold microenvironment requires T helper 2 cells. Science. 352:366–370, 2016.CrossRefPubMedCentralPubMedGoogle Scholar
  27. 27.
    Sivashankari, P. R., and M. Prabaharan. Prospects of chitosan-based scaffolds for growth factor release in tissue engineering. Int. J. Biol. Macromol. 93:1382–1389, 2016.CrossRefPubMedGoogle Scholar
  28. 28.
    Spivey, E. C., Z. Z. Khaing, J. B. Shear, and C. E. Schmidt. The fundamental role of subcellular topography in peripheral nerve repair therapies. Biomaterials. 33:4264–4276, 2012.CrossRefPubMedGoogle Scholar
  29. 29.
    Tang, X., H. Qin, X. Gu, and X. Fu. China’s landscape in regenerative medicine. Biomaterials. 124:78–94, 2017.CrossRefPubMedGoogle Scholar
  30. 30.
    Tang, X., Y. Wang, S. Zhou, T. Qian, and X. Gu. Signaling pathways regulating dose-dependent dual effects of TNF-alpha on primary cultured Schwann cells. Mol. Cell Biochem. 378:237–246, 2013.CrossRefPubMedGoogle Scholar
  31. 31.
    Tang, X., C. Xue, Y. Wang, F. Ding, Y. Yang, and X. Gu. Bridging peripheral nerve defects with a tissue engineered nerve graft composed of an in vitro cultured nerve equivalent and a silk fibroin-based scaffold. Biomaterials. 33:3860–3867, 2012.CrossRefPubMedGoogle Scholar
  32. 32.
    Tzekova, N., A. Heinen, S. Bunk, C. Hermann, H. P. Hartung, B. Reipert, et al. Immunoglobulins stimulate cultured Schwann cell maturation and promote their potential to induce axonal outgrowth. J. Neuroinflamm. 12:107, 2015.CrossRefGoogle Scholar
  33. 33.
    Vargas, M. E., J. Watanabe, S. J. Singh, W. H. Robinson, and B. A. Barres. Endogenous antibodies promote rapid myelin clearance and effective axon regeneration after nerve injury. PNAS. 107:11993–11998, 2010.CrossRefPubMedCentralPubMedGoogle Scholar
  34. 34.
    Wang, Y., X. Tang, B. Yu, Y. Gu, Y. Yuan, D. Yao, et al. Gene network revealed involvements of Birc2, Birc3 and Tnfrsf1a in anti-apoptosis of injured peripheral nerves. PLoS ONE. 7:e43436, 2012.CrossRefPubMedCentralPubMedGoogle Scholar
  35. 35.
    Wong, K. M., E. Babetto, and B. Beirowski. Axon degeneration: make the Schwann cell great again. Neural Regen. Res. 12:518–524, 2017.CrossRefPubMedCentralPubMedGoogle Scholar
  36. 36.
    Yang, Y., W. Zhao, J. He, Y. Zhao, F. Ding, and X. Gu. Nerve conduits based on immobilization of nerve growth factor onto modified chitosan by using genipin as a crosslinking agent. Eur. J. Pharm. Biopharm. 79:519–525, 2011.CrossRefPubMedGoogle Scholar
  37. 37.
    Yi, S., X. Tang, J. Yu, J. Liu, F. Ding, and X. Gu. Microarray and qPCR analyses of wallerian degeneration in rat sciatic nerves. Front. Cell. Neurosci. 11:22, 2017.PubMedCentralPubMedGoogle Scholar
  38. 38.
    Zhao, Y., Y. Wang, J. Gong, L. Yang, C. Niu, X. Ni, et al. Chitosan degradation products facilitate peripheral nerve regeneration by improving macrophage-constructed microenvironments. Biomaterials. 134:64–77, 2017.CrossRefPubMedGoogle Scholar

Copyright information

© Biomedical Engineering Society 2018

Authors and Affiliations

  • Li Zhang
    • 1
  • Weijia Zhao
    • 1
    • 2
  • Changmei Niu
    • 1
  • Yujie Zhou
    • 3
  • Haiyan Shi
    • 1
  • Yalin Wang
    • 1
  • Yumin Yang
    • 1
  • Xin Tang
    • 1
  1. 1.Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of NeuroregenerationNantong UniversityNantongChina
  2. 2.Department of Life Sciences of Medical SchoolNantong UniversityNantongChina
  3. 3.Department of Pathophysiology of Medical SchoolNantong UniversityNantongChina

Personalised recommendations